Top 10 Medical Equipment Stocks with Highest Upside: CBMX, BLTI, OTIX, APT, WHRT, DCTH, DSCI, VITA, ANPI, SLTM (Jul 26, 2010)

Below are the top 10 Medical Equipment stocks with highest upside potential, based on the difference between current price and Wall Street analysts' average target price.

CombiMatrix Corporation (NASDAQ:CBMX) has the 1st highest upside potential in this segment of the market. Its upside is 429.8%. Its consensus target price is $15.00 based on the average of all estimates. Biolase Technology, Inc. (NASDAQ:BLTI) has the 2nd highest upside potential in this segment of the market. Its upside is 308.2%. Its consensus target price is $4.00 based on the average of all estimates. Otix Global, Inc. (NASDAQ:OTIX) has the 3rd highest upside potential in this segment of the market. Its upside is 293.7%. Its consensus target price is $15.00 based on the average of all estimates. Alpha Pro Tech, Ltd. (AMEX:APT) has the 4th highest upside potential in this segment of the market. Its upside is 194.5%. Its consensus target price is $5.63 based on the average of all estimates. WorldHeart Corporation (USA) (NASDAQ:WHRT) has the 5th highest upside potential in this segment of the market. Its upside is 166.0%. Its consensus target price is $7.50 based on the average of all estimates.

Delcath Systems, Inc. (NASDAQ:DCTH) has the 6th highest upside potential in this segment of the market. Its upside is 158.2%. Its consensus target price is $20.38 based on the average of all estimates. Derma Sciences, Inc. (NASDAQ:DSCI) has the 7th highest upside potential in this segment of the market. Its upside is 151.5%. Its consensus target price is $13.00 based on the average of all estimates. Orthovita, Inc. (NASDAQ:VITA) has the 8th highest upside potential in this segment of the market. Its upside is 142.6%. Its consensus target price is $4.54 based on the average of all estimates. Angiotech Pharmaceuticals, Inc. (USA) (NASDAQ:ANPI) has the 9th highest upside potential in this segment of the market. Its upside is 138.9%. Its consensus target price is $1.50 based on the average of all estimates. Solta Medical Inc. (NASDAQ:SLTM) has the 10th highest upside potential in this segment of the market. Its upside is 117.7%. Its consensus target price is $3.57 based on the average of all estimates.